{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:12:00Z","timestamp":1780517520614,"version":"3.54.1"},"publisher-location":"Chichester, UK","reference-count":74,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004734.pub3","type":"reference-entry","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T17:07:29Z","timestamp":1233680849000},"source":"Crossref","is-referenced-by-count":37,"title":["Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome"],"prefix":"10.1002","author":[{"given":"Stef","family":"Kaandorp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Goddijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD004734.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.fertnstert.2005.12.068","article-title":"A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages","volume":"86","author":"Dolitzky","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/12.Suppl_2.191","article-title":"Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD004734.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)00202-2","article-title":"Low-molecular-weight heparin for thrombophilia in pregnant women","volume":"69","author":"Bar","year":"2000","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD004734.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0049-3848(00)00413-8","article-title":"Effect of thromboprophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications","volume":"101","author":"Bar","year":"2001","journal-title":"Thrombosis Research"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/107602960000600301","article-title":"Recurrent miscarriage syndrome due to blood coagulation protein\/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group","volume":"6","author":"Bick","year":"2000","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1002\/14651858.CD004734.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"11 Pt 1","key":"10.1002\/14651858.CD004734.pub3-BIB11|cit9","first-page":"702a","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss. The LIVE-ENOX study","volume":"100","author":"Brenner","year":"2002","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004734.pub3-BIB9|cit10","first-page":"Abstract number","article-title":"Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"1 Suppl 1","author":"Brenner","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub3-BIB10|cit11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD004734.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ajog.2004.09.049","article-title":"Efficacy of enoxaparin for improving pregnancy outcomes and uteroplacental blood flow in women with thrombophilia and recurrent pregnancy loss","volume":"191","author":"Thaler","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004734.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0015-0282(02)03222-3","article-title":"Preventing adverse obstetric outcomes in women with genetic thrombophilia","volume":"78","author":"Grandone","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653781","article-title":"Use of a low-molecular-weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity","volume":"73","author":"Gris","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1002\/14651858.CD004734.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004734.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0015-0282(01)01819-2","article-title":"Low-dose aspirin is effective for treatment of recurrent miscarriage in patients with decreased coagulation factor XII","volume":"76","author":"Ogasawara","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD004734.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/humrep\/15.10.2220","article-title":"Recurrent miscarriage-an aspirin a day?","volume":"15","author":"Rai","year":"2000","journal-title":"Human Reproduction"},{"issue":"8","key":"10.1002\/14651858.CD004734.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/humrep\/14.8.2106","article-title":"Habitual abortions in 678 healthy patients: investigation and prevention","volume":"14","author":"Reznikoff-Etievant","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub3-BIB21|cit21","first-page":"Abstract number","article-title":"Modulation of systemic and placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications","volume":"1 Suppl 1","author":"Sarig","year":"2003","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1002\/14651858.CD004734.pub3-BIB22|cit22","first-page":"406","article-title":"Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia","volume":"61","author":"Sarto","year":"2001","journal-title":"Medicina"},{"key":"10.1002\/14651858.CD004734.pub3-BIB23|cit23","first-page":"655","article-title":"Birth outcomes in pregnant women treated with low-molecular-weight heparin","volume":"79","author":"Sorensen","year":"2000","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD004734.pub3-BIB24|cit24","first-page":"267","article-title":"Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriage of unknown etiology","volume":"29","author":"Tzafettas","year":"2002","journal-title":"Clinical and Experimental Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004734.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-0528.2000.tb13240.x","article-title":"The effect of thromboprophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V mutation","volume":"107","author":"Younis","year":"2000","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD004734.pub3-BIB26|cit26","unstructured":"Middeldorp S Aspirin and\/or low molecular weight heparin for women with unexplained recurrent miscarriage and\/or intra-uterine fetal death Netherlands Trial Register (http:\/\/www.trialregister.nl)"},{"key":"10.1002\/14651858.CD004734.pub3-BIB27|cit27","unstructured":"Schleussner E Effectiveness of dalteparin therapy as intervention in recurrent pregnancy loss http:\/\/controlled-trials.com"},{"key":"10.1002\/14651858.CD004734.pub3-BIB28|cit28","unstructured":"Clark P The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss National Research Register (www.nrr.nhs.uk)"},{"key":"10.1002\/14651858.CD004734.pub3-BIB29|cit29","unstructured":"Rodgers M Thrombophilia in pregnancy prophylaxis study (TIPPS) Ottawa Health Research Institute - http:\/\/www.ohri.ca"},{"key":"10.1002\/14651858.CD004734.pub3-BIB30|cit30","first-page":"179","article-title":"ACOG practice bulletin: management of recurrent early pregnancy loss","volume":"78","year":"2002","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD004734.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/oxfordjournals.humrep.a137135","article-title":"Cytogenetic studies in couples experiencing repeated pregnancy losses","volume":"5","author":"Braekeleer","year":"1990","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/humrep\/14.11.2868","article-title":"A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage","volume":"14","author":"Brigham","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.fertnstert.2004.12.018","article-title":"Evidence-based investigations and treatments of recurrent pregnancy loss","volume":"83","author":"Christiansen","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD004734.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.gco.0000193011.73405.07","article-title":"Evidence-based investigations and treatments of recurrent pregnancy loss","volume":"18","author":"Christiansen","year":"2006","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004734.pub3-BIB35|cit35","unstructured":"Clarke M Oxman AD Cochrane Reviewers' Handbook 4.1.5 [updated April 2002] In: The Cochrane Library. Issue 2, 2002. Oxford: Updated Software. updated quarterly"},{"key":"10.1002\/14651858.CD004734.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/oxfordjournals.humrep.a138703","article-title":"An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases","volume":"9","author":"Clifford","year":"1994","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00001703-199510000-00006","article-title":"Recurrent pregnancy loss","volume":"7","author":"Cook","year":"1995","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004734.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0002-9378(97)70205-9","article-title":"Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction","volume":"177","author":"Dizon","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub3-BIB39|cit39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002859.pub2","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004734.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/bmj.315.7099.32","article-title":"Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice","volume":"315","author":"Everett","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004734.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD004734.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/bmj.38498.669595.8F","article-title":"Selective chromosome analysis in couples with two or more miscarriages: case-control study","volume":"331","author":"Franssen","year":"2005","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1002\/14651858.CD004734.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.119.1_suppl.122S","article-title":"Use of antithrombotic agents during pregnancy","volume":"119","author":"Ginsberg","year":"2001","journal-title":"Chest"},{"key":"10.1002\/14651858.CD004734.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/j.1600-0412.2001.080006568.x","article-title":"Complications of induced abortion and miscarriage in three African Countries: a hospital-based study among WHO collaborating centres","volume":"80","author":"Goyaux","year":"2001","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub3-BIB45|cit45","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003511.pub2","article-title":"Progestogen for preventing miscarriage","author":"Haas","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004734.pub3-BIB46|cit46","first-page":"6","volume-title":"Spontaneous abortion","author":"Huisjes","year":"1984"},{"key":"10.1002\/14651858.CD004734.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199110103251503","article-title":"Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study","volume":"325","author":"Infante-Reviard","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004734.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1093\/humrep\/del150","article-title":"Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage","volume":"21","author":"Jauniaux","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","article-title":"Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"340","author":"Kupferminc","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004734.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub3-BIB51|cit51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-3999(95)00579-X","article-title":"Miscarriage as a traumatic event: a review of the literature and new implications for intervention","volume":"40","author":"Lee","year":"1996","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD004734.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004734.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1538-7836.2006.01839.x","article-title":"The natural course of women with recurrent fetal loss","volume":"4","author":"Lindqvist","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0037-1615891","article-title":"Pregnancy loss in the antiphospholipid syndrome","volume":"82","author":"Lockshin","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden","volume":"130","author":"Meinardi","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004734.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1538-7836.2007.02501.x","article-title":"Thrombophilia and pregnancy complications: cause or association?","volume":"5 Suppl 1","author":"Middeldorp","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/15.8.1830","article-title":"Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?","volume":"15","author":"Mousa","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub3-BIB58|cit58","volume-title":"Report on Maternal Deaths in Australia 1994-96. Canberra","year":"2001"},{"key":"10.1002\/14651858.CD004734.pub3-BIB59|cit59","unstructured":"Ankum WM Erwich JJHM Geraedts JPM Goddijn M Land JA Macklon NS Recurrent miscarriage (dutch: herhaalde miskraam) www.nvog.nl (Dutch obstetrics & gynaecology guidelines)"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub3-BIB60|cit60","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000112.pub2","article-title":"Immunotherapy for recurrent miscarriage","author":"Porter","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004734.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004734.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/oxfordjournals.humrep.a136224","article-title":"Antiphospholipid antibodies and beta2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive approach","volume":"10","author":"Rai","year":"1995","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD004734.pub3-BIB63|cit63","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1471-0528.1996.tb09887.x","article-title":"Placental thrombosis and second trimester miscarriage in association with activated protein C resistance","volume":"103","author":"Rai","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004734.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004734.pub3-BIB65|cit65","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4471-1658-5_4","article-title":"A prospective study of spontaneous abortion","volume-title":"Early pregnancy loss: mechanisms and treatment","author":"Regan","year":"1988"},{"key":"10.1002\/14651858.CD004734.pub3-BIB66|cit66","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2000"},{"key":"10.1002\/14651858.CD004734.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004734.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4471-1658-5_16","article-title":"Placental pathology in spontaneous miscarriage","volume-title":"Early pregnancy loss: mechanisms and treatment","author":"Rushton","year":"1988"},{"issue":"3","key":"10.1002\/14651858.CD004734.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1650282","article-title":"The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women","volume":"75","author":"Sanson","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy. A systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004734.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0140-6736(90)92159-F","article-title":"Recurrent miscarriage: definition and epidemiology","volume":"336","author":"Stirrat","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub3-BIB72|cit72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003580","article-title":"Heparin for pregnant women with acquired or inherited thrombophilias","author":"Walker","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004734.pub3-BIB73|cit73","first-page":"246","article-title":"Recommended definitions; terminology and format for statistical tables related to the perinatal period","volume":"56","year":"1977","journal-title":"Acta Obstetricia et Gynecologica Scandinavica\u00a0"},{"issue":"2","key":"10.1002\/14651858.CD004734.pub3-BIB74|cit74","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004734.pub2","article-title":"Aspirin or anticoagulants for the treatment of recurrent miscarriage in women without antiphospholipid syndrome","author":"Nisio","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004734.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T00:00:00Z","timestamp":1404432000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004734.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:39:12Z","timestamp":1628545152000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004734.pub3"}},"subtitle":[],"editor":[{"given":"Stef","family":"Kaandorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":74,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004734.pub3","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004734.pub4","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2009,1,21]]}}}